...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Presentations & Events

I've sent in a e-mail to IR requesting an updated presentations & event list for both RVX & Zenith. Maybe it will give us something to look forward too.If i receive anything back I'll put it up

Share
New Message
Please login to post a reply